Our results proved that DUXAP8 was upregulated in HCC tissues, and patients with high expression of DUXAP8 had poor prognosis, and knocking down DUXAP8 inhibited the malignant phenotypes of HCC cells. This evidence concerns the gene DUXAP8 and hepatocellular carcinoma.